DBJP:NYE-Xtrackers MSCI Japan Hedged Equity ETF (USD)

ETF | Japan Stock |

Last Closing

USD 70.27

Change

0.00 (0.00)%

Market Cap

USD 0.44B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund, using a passive or indexing investment approach, seeks investment results that correspond generally to the performance, of the underlying index, which is designed to track the performance of the Japanese equity market while mitigating exposure to fluctuations between the value of the U.S. dollar and the Japanese yen. It will invest at least 80% of its total assets in component securities (including depositary receipts in respect of such securities) of the underlying index.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing DBJP

CNDA Concord Acquisition Corp .. 0.00 % 0.70 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.27% 60% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.27% 60% D- 65% D
Trailing 12 Months  
Capital Gain 16.75% 60% D- 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.75% 60% D- 52% F
Trailing 5 Years  
Capital Gain 76.47% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.47% 80% B- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 15.41% N/A N/A 79% B-
Dividend Return 18.42% N/A N/A 79% B-
Total Return 3.01% N/A N/A 60% D-
Risk Return Profile  
Volatility (Standard Deviation) 15.25% N/A N/A 64% D
Risk Adjusted Return 120.79% N/A N/A 99% N/A
Market Capitalization 0.44B 67% D+ 46% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.